NPI: 1265460232 · FORT LAUDERDALE, FL 33308 · General Acute Care Hospital · NPI assigned 06/29/2006
Authorized official BERT, ALISA controls 20+ related entities in our dataset. Read more
| Authorized Official | BERT, ALISA (INTERIM CFO) |
| Parent Organization | NORTH BROWARD HOSPITAL DISTRICT |
| NPI Enumeration Date | 06/29/2006 |
Other providers sharing the same authorized official: BERT, ALISA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,279 | $290K |
| 2019 | 51,756 | $438K |
| 2020 | 41,694 | $395K |
| 2021 | 55,172 | $841K |
| 2022 | 52,137 | $1.31M |
| 2023 | 26,092 | $825K |
| 2024 | 9,576 | $359K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,844 | 11,177 | $951K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,940 | 11,523 | $941K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,008 | 5,662 | $449K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,711 | 1,482 | $280K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,872 | 2,317 | $244K |
| G0378 | Hospital observation service, per hour | 5,960 | 3,112 | $228K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,769 | 3,182 | $183K |
| 36415 | Collection of venous blood by venipuncture | 18,826 | 11,983 | $144K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,162 | 1,955 | $140K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 947 | 779 | $117K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,605 | 2,741 | $89K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,391 | 6,190 | $78K |
| 80053 | Comprehensive metabolic panel | 17,335 | 13,516 | $61K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,905 | 1,568 | $52K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,025 | 1,708 | $38K |
| 87631 | 378 | 363 | $37K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,858 | 3,487 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,412 | 2,885 | $23K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,518 | 778 | $20K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 313 | 263 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21,725 | 14,706 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,819 | 3,197 | $19K |
| 87070 | 1,148 | 1,005 | $19K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 486 | 360 | $18K |
| 71046 | Radiologic examination, chest; 2 views | 1,568 | 1,328 | $17K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 591 | 489 | $17K |
| 71045 | Radiologic examination, chest; single view | 7,164 | 5,846 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,565 | 936 | $13K |
| 81001 | 8,042 | 6,765 | $11K | |
| 87486 | 347 | 323 | $11K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,453 | 1,630 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | 441 | 319 | $11K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 381 | 251 | $10K |
| 83735 | 7,274 | 5,037 | $8K | |
| J2704 | Injection, propofol, 10 mg | 2,111 | 1,635 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,234 | 3,306 | $8K |
| 81025 | 2,024 | 1,878 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,918 | 5,369 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2,512 | 2,039 | $7K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,015 | 1,720 | $6K |
| 81003 | 1,334 | 1,085 | $6K | |
| 87077 | 646 | 474 | $6K | |
| 84484 | 4,115 | 2,707 | $5K | |
| 85610 | 4,265 | 3,337 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,720 | 1,534 | $5K |
| 85730 | 3,960 | 3,132 | $5K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 694 | 595 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,828 | 3,170 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 389 | 338 | $4K |
| 83690 | 3,418 | 2,889 | $3K | |
| 87186 | 1,168 | 872 | $3K | |
| 82550 | 3,135 | 2,497 | $3K | |
| 87210 | 152 | 141 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 34 | 27 | $2K |
| 73630 | 154 | 130 | $2K | |
| 83880 | 912 | 713 | $2K | |
| 84703 | 3,630 | 3,213 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 13 | 13 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,969 | 1,326 | $2K |
| 87040 | 1,467 | 1,081 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,028 | 3,383 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,037 | 2,816 | $1K |
| 83605 | 1,508 | 1,151 | $1K | |
| 86850 | 864 | 708 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 325 | 279 | $1K |
| 84702 | 919 | 759 | $916.93 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 316 | 294 | $809.12 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 545 | 323 | $772.00 |
| 76830 | Ultrasound, transvaginal | 68 | 66 | $629.47 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | 16 | $604.36 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 13 | 12 | $536.71 |
| 73030 | 115 | 77 | $534.33 | |
| 93971 | 84 | 65 | $506.67 | |
| 85379 | 319 | 289 | $476.01 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 28 | 28 | $444.89 |
| 71275 | Computed tomographic angiography, chest, with contrast material | 15 | 14 | $422.54 |
| 87581 | 347 | 323 | $412.39 | |
| A9270 | Non-covered item or service | 1,430 | 600 | $382.55 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 348 | 325 | $367.33 |
| 87088 | 553 | 435 | $325.52 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 494 | 356 | $314.06 |
| 80329 | 74 | 71 | $281.18 | |
| 87430 | 715 | 684 | $270.12 | |
| 86900 | 1,039 | 868 | $265.50 | |
| 74022 | 86 | 73 | $158.89 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 73 | 60 | $154.08 |
| 80320 | 103 | 98 | $151.60 | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,456 | 1,222 | $147.68 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 447 | 381 | $128.81 |
| 87205 | 22 | 14 | $112.82 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 805 | 656 | $102.41 |
| 86901 | 1,039 | 867 | $100.32 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 124 | 88 | $100.00 |
| 73564 | 17 | 12 | $51.66 | |
| 80061 | Lipid panel | 27 | 26 | $44.01 |
| J2060 | Injection, lorazepam, 2 mg | 634 | 442 | $40.00 |
| J3490 | Unclassified drugs | 338 | 178 | $34.23 |
| 83036 | Hemoglobin; glycosylated (A1C) | 147 | 126 | $31.14 |
| 84100 | 85 | 53 | $23.78 | |
| 86140 | 133 | 104 | $20.77 | |
| J1630 | Injection, haloperidol, up to 5 mg | 248 | 190 | $2.66 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 109 | 66 | $2.58 |
| 84439 | 20 | 12 | $2.57 | |
| 84132 | 93 | 76 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 215 | 124 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 106 | 77 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 61 | 36 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 49 | 28 | $0.00 |
| 96376 | 67 | 51 | $0.00 | |
| 85651 | 17 | 12 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 90 | 42 | $0.00 |
| 00731 | 14 | 13 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 44 | 29 | $0.00 |
| 88312 | 12 | 12 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 73 | 60 | $0.00 |
| 74018 | 12 | 12 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 65 | 62 | $0.00 |
| 72110 | 32 | 18 | $0.00 | |
| 88313 | 12 | 12 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 13 | 13 | $0.00 |
| 73130 | 15 | 14 | $0.00 |